Point72 Hong Kong Ltd - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 92 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2019$10,254,000
-3.1%
107,592
-7.2%
2.81%
-32.7%
Q1 2019$10,579,000
+88.7%
115,939
+57.0%
4.17%
+59.1%
Q4 2018$5,607,000
+48.2%
73,870
+56.2%
2.62%
+102.8%
Q3 2018$3,784,000
-63.3%
47,296
-54.4%
1.29%
-62.9%
Q2 2018$10,310,000103,7973.49%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders